Insider: Hohl Benjamin CHIEF FINANCIAL OFFICER - Enliven Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 23,000 | 0 | 23,000 |
| Value | $435,160.00 | $0.00 | $435,160.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/27/2025 | DDS | 3,250 | Direct | COM | $20.63 | $67,038.73 | 23,000 |
| 07/28/2025 | DDS | 3,185 | Direct | COM | $20.45 | $65,119.24 | 23,065 |
| 07/28/2025 | DDS | 65 | Direct | COM | $21.30 | $1,384.52 | 23,000 |
| 07/10/2025 | DDS | 1,000 | Direct | COM | $22.66 | $22,655.00 | 23,000 |
| 06/27/2025 | DDS | 3,052 | Direct | COM | $20.86 | $63,667.47 | 23,198 |
| 06/27/2025 | DDS | 198 | Direct | COM | $21.66 | $4,288.34 | 23,000 |
| 06/13/2025 | DDS | 3,000 | Direct | COM | $22.55 | $67,655.40 | 23,000 |
| 05/27/2025 | DDS | 3,250 | Direct | COM | $16.18 | $52,593.45 | 23,000 |
| 04/28/2025 | DDS | 3,181 | Direct | COM | $18.68 | $59,418.54 | 23,069 |
| 04/28/2025 | DDS | 69 | Direct | COM | $19.12 | $1,319.02 | 23,000 |
| 03/27/2025 | DDS | 3,250 | Direct | COM | $21.33 | $69,320.88 | 23,000 |
| 03/24/2025 | DDS | 1,000 | Direct | COM | $22.50 | $22,504.50 | 23,000 |
| 02/27/2025 | DDS | 3,250 | Direct | COM | $20.41 | $66,326.98 | 13,000 |
| 02/05/2025 | DDS | 1,000 | Direct | COM | $22.52 | $22,524.40 | 13,000 |
| 01/27/2025 | DDS | 3,250 | Direct | COM | $21.59 | $70,177.90 | 13,000 |
| 12/30/2024 | DDS | 900 | Direct | COM | $22.51 | $20,255.49 | 0 |
| 12/27/2024 | DDS | 3,350 | Direct | COM | $22.15 | $74,218.92 | 0 |
| 11/27/2024 | DDS | 4,250 | Direct | COM | $24.78 | $105,312.88 | 1,000 |
| 11/27/2024 | DDS | 1,000 | Direct | COM | $25.38 | $25,375.50 | 0 |
| 10/28/2024 | DDS | 5,600 | Direct | COM | $28.49 | $159,562.48 | 650 |
| 10/28/2024 | DDS | 650 | Direct | COM | $29.11 | $18,922.15 | 0 |
| 10/18/2024 | DDS | 814 | Direct | COM | $30.00 | $24,422.44 | 0 |
| 10/01/2024 | DDS | 521 | Direct | COM | $27.54 | $14,346.88 | 0 |
| 08/27/2024 | DDS | 4,250 | Direct | COM | $22.54 | $95,781.83 | 0 |
| 07/31/2024 | DDS | 991 | Direct | COM | $27.53 | $27,280.94 | 0 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research